---
title: USJCMSP 2024 EID
---

- [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
- [Contact Us](https://www.crdfglobal.org/contact-us/)

[Facebook](https://www.facebook.com/CRDFGlobal) <https://twitter.com/CRDFGlobal> [Instagram](https://www.instagram.com/crdfglobal/)[Linkedin](https://www.linkedin.com/company/crdf-global)

[![](https://insights.crdfglobal.org/hubfs/crdf-logo.svg)](https://crdfglobal.org/)

- WHO WE ARE
  
  #### [Our Story](https://crdfglobal.org/our-story/)
  
  #### [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
  
  #### [Leadership](https://crdfglobal.org/leadership)
  
  #### [Our Experts](https://crdfglobal.org/experts)
  
  #### [Clients & Partners](https://crdfglobal.org/partners)

  ![Who we are mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/06/who-we-are-menu.jpg)
  
  More than 30 years advancing international security, technology, and economic progress in over 120 countries.
- WHAT WE DO
  
  #### [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
  
  #### [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
  
  #### [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)

  #### [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
  
  #### [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
  
  #### [Health Security and Research](https://www.crdfglobal.org/what-we-do/global-health/)

  ![What we do mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/07/MegaMenu_Website_Images_Ratios_SizesWhat-We-Do-Mega-Menu.png)
  
  Addressing evolving security and prosperity challenges through strategically tailored solutions.
- HOW WE DELIVER
  
  ### CORE CAPABILITIES
  
  #### [Travel & Logistics](https://crdfglobal.org/capabilities/travel-logistics/)
  
  #### [Specialized Equipment Procurement](https://crdfglobal.org/capabilities/specialized-equipment-procurement/)
  
  #### [Technical & Professional Trainings](https://crdfglobal.org/capabilities/technical-and-professional-trainings/)
  
  #### [Fellowships & Exchanges](https://crdfglobal.org/capabilities/fellowships-and-exchanges/)
  
  #### [Grants & Research Competitions](https://crdfglobal.org/capabilities/grants-research-competitions/)
  
  #### [Security Strengthening](https://crdfglobal.org/capabilities/security-strengthening/)

  ### INTEGRATED SOLUTIONS
  
  #### [Program Design and Management](https://crdfglobal.org/integrated-solutions/program-design-and-management/)
  
  #### [Quality Framework](https://crdfglobal.org/integrated-solutions/quality-framework/)
  
  #### [Monitoring, Evaluation and Learning](https://crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
  
  #### [Remote Training & Learning](https://crdfglobal.org/integrated-solutions/remote-training-and-learning/)

  ![How we deliver mega menu](https://www.crdfglobal.org/wp-content/uploads/2022/01/how-we-deliver-menu-v2.jpg)
  
  Recognized leader in global program delivery, combining technical expertise with flexible, locally driven solutions.
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/)
- [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
- [CAREERS](https://crdfglobal.org/careers/)

- [\> Home](https://insights.crdfglobal.org/usjcmspeid2024)
- [\> General Registration](https://insights.crdfglobal.org/usjcmspeid2024-1)
- [\> Speaker Registration](https://insights.crdfglobal.org/usjcmspeid2024-1-1)
- [\> Plenary Agenda](https://insights.crdfglobal.org/usjcmspeid2024-agenda)
- [\> Panel Agendas](https://insights.crdfglobal.org/usjcmspeid2024panels)
- [\> Travel Information](https://insights.crdfglobal.org/usjcmspeid2024-travel)
- [\> IDRIC Symposium](https://idric.kr/)
- [\> Abstract eBooks](https://insights.crdfglobal.org/usjcmspeid2024_ebooks)

---

![USJCMSP logo5 title](https://insights.crdfglobal.org/hs-fs/hubfs/USJCMSP%20logo5%20title.jpg?width=300&height=179&name=USJCMSP%20logo5%20title.jpg "USJCMSP logo5 title")

## The Joint 24th International Conference on Emerging Infectious Diseases in the Pacific Rim of the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) in collaboration with the 2nd International Symposium for Infectious Diseases Research Institutes Cooperation (IDRIC)

![logo1 (003)](https://insights.crdfglobal.org/hs-fs/hubfs/logo1%20(003).png?width=125&height=125&name=logo1%20(003).png "logo1 (003)")

![NIH\_Master\_Logo\_Vertical\_2Color-PNG (002)](https://insights.crdfglobal.org/hs-fs/hubfs/NIH_Master_Logo_Vertical_2Color-PNG%20(002).png?width=125&height=110&name=NIH_Master_Logo_Vertical_2Color-PNG%20(002).png "NIH_Master_Logo_Vertical_2Color-PNG (002)")

![KDCA\_KNIH\_KNIID LOGO change](https://insights.crdfglobal.org/hs-fs/hubfs/KDCA_KNIH_KNIID%20LOGO%20change.jpg?width=350&height=58&name=KDCA_KNIH_KNIID%20LOGO%20change.jpg "KDCA_KNIH_KNIID LOGO change")

![IVI\_logo (002)-1](https://insights.crdfglobal.org/hs-fs/hubfs/IVI_logo%20(002)-1.png?width=250&name=IVI_logo%20(002)-1.png "IVI_logo (002)-1")

Disclaimer: The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policies of the Department of Health and Human Services (HHS), nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

---

### Viral Diseases Panel Agenda

###### Thursday| 7 March 2024 | DAY THREE

8:30-9:00 | Registration

9:00-9:05 | Welcome Remarks

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION ONE: Rabies

*Moderator: Akira Nishizono*

9:05-9:30 | Exploring Host Gene Expression Dynamics in Lymph Node Inoculated with Different Pathogenic Rabies Virus | Kazunori Kimitsuki, Oita University, Japan

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION TWO: Hemorrhagic Viruses

*Moderator: Asika Nanbo*

9:30-9:55 | The role of the NP as a Type I interferon antagonist in the Arenavirus replication | Shuza Urata, Nagasaki, Japan

9:55-10:20 | Overview of the Institute Pasteur Korea | Sung Key Jang, Institute Pasteur Korea, South Korea

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

10:20-11:00 | Coffee Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

11:00-11:25 | Analysis of host factors on viral replication cycle of Crimean-Congo hemorrhagic fever virus | Minato Hirano, Nagasaki, Japan

11:25-11:50 | Severe Fever with Thrombocytopenia Syndrome Virus: Prevalence and its age-dependent pathogenesis | Choi Young Ki, KVRI, South Korea

11:50-12:05 | Flash Talks | 3-5 Minutes Each

- Morphological and Pathological Features of Oita Virus, a Bat-Borne Rhabdovirus | **Sakirul Khan** (Oita University, Japan)
- Development of a visualizing system for the Ebola virus glycoprotein | Wakako Furuyama (Nagasaki University, Japan)
- Substitution of E1497K in L protein changes plaque phenotype and growth kinetics of Guanarito virus S-26764 strain | Satoshi Taniguchi (NIID, Japan)

 

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

12:05-13:25 | Lunch & Poster Viewing

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION THREE: Enteric Viruses

*Moderator: Craig Cameron & Takeshi Kobayashi* 

13:30-13:55 | Neonatal Fc receptor works as a classical human astrovirus receptor | Kei Haga (Kitasato University, Japan)

13:55-14:20 | Development of therapeutics to treat infection by RNA viruses | Craig Cameron, University of North Carolina, USA

14:20-14:45 | Do nutrients also help norovirus to infect in the small intestine? | Sakura Kobayashi - National Institute of Infectious Diseases, Japan

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

14:45-15:15 | Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

15:15-15:40 | The last hurdles on the path to poliovirus eradication and new tools to achieve it | Ondrej Mach, World Health Organization, Switzerland virtual 

15:40-16:05 | Enabling high dose RNA vaccination for development of a multivalent enterovirus vaccine | Jesse Eramus, HDT Bio, USA

16:05-16:20| Flash Talks | 3-5 Minutes Each

- Dissection of the mechanism of rotavirus inclusion body formation with a focus on viral NSP2 protein | **Tomohiro Kotaki**, Osaka University, Japan
- Genetic engineering strategy for generating a stable dsRNA virus vector using a virus-like codon-modified transgene | **Yuta Kanai**, Osaka University, Japan
- Development of *in vitro* - assembled multivalent VLP vaccine for norovirus infection | **Deog-Young Choi**, InThera Inc., South Korea

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION FOUR: Arboviruses

*Moderator: Richard Kuhn & Hiroaki Kariwa*

16:20-16:45 | Beyond retroviruses: new effector functions for the antiviral restriction factor, TRIM5 | Sonja Best, National Institute of Allergy and Infectious Disease, RML, USA

16:45-17:10 | Zika virus NS5 forms nuclear-body structures via conjugation to small ubiquitin-like modifier on a lineage-specific lysine to modulate virus pathogenicity | Dimitri Lavillette, Pastuer, South Korea

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

###### Friday| 8 March 2024 | DAY FOUR

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION FOUR: Arboviruses continued

*Moderator: Richard Kuhn*

8:30-8:55 | West Nile virus capsid protein induces nuclear membrane loss and promotes viral replication | Shintaro Kobayashi, Hokkaido, Japan

8:55-9:20 | Structural and biochemical studies of flaviviruses in complex with antibodies and attachment factors | Richard Kuhn, Purdue University, USA

9:20-9:45 | Longitudinal analysis of Dengue virus-1 (DENV-1) infection induced cross-neutralization and antibody-dependent enhancement activity across genotypes levels and T-cell epitopes | Moi Meng Ling, University of Tokyo, Japan

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

9:45-10:25 | Coffee Break

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

SESSION FIVE: Bat Immunology & Zoonotic Viruses

*Moderator: Eun-Chung Park*

10:25-10:50 | Studies of MPOX | Anne Rimion, University of California Los Angelas, USA (virtual)

10:50-11:15 | Poxvirus sabotage of T-cell co-stimulation | Daved Fremont, Washington University, USA

11:15-11:40 | Antiviral immunity of the Australian black flying fox to Hendra virus | Michelle Baker, Centre for Disease Preparedness, Australia 

11:40-12:05 | Understanding persistence of potentially zoonotic, bat-borne henipaviruses in Madagascar | Cara Brook, University of Chicago, USA

12:05-12:30 | Niemann-Pick C1 heterogeneity and filovirus tropism to bat cells | Ayato Takada, Hokkaido University, Japan

12:30-12:40 | CLOSING REMARKS

\_

---

## If you have any questions or technical issues please contact Annie King, [aking@crdfglobal.org](mailto:aking@crdfglobal.org)

![](https://www.crdfglobal.org/wp-content/uploads/2021/12/crdf-logo-white.svg)

#### Advancing U.S. national security by mitigating threats and enhancing opportunities through technology, innovation, and collaboration.

### Let us know how we can help you reach your goals

[Facebook Facebook](https://www.facebook.com/CRDFGlobal) [Twitter](https://twitter.com/CRDFGlobal) [Instagram Instagram](https://www.instagram.com/crdfglobal/) [Linkedin Linkedin](https://www.linkedin.com/company/crdf-global)[Contact Us](https://insights.crdfglobal.org/contact-us?hsLang=en)

- WHO WE ARE 
    - [Our Story](https://crdfglobal.org/our-story/)
    - [Mission, Vision & Values](https://crdfglobal.org/mission-vision-values/)
    - [Leadership](https://insights.crdfglobal.org/leadership?hsLang=en)
    - [Our Experts](https://insights.crdfglobal.org/experts?hsLang=en)
    - [Partners](https://insights.crdfglobal.org/partners?hsLang=en)
- WHAT WE DO 
    - [Chemical, Biological & Nuclear Security](https://www.crdfglobal.org/what-we-do/cbrne-security-counterproliferation/)
    - [Cybersecurity & Digital Resilience](https://www.crdfglobal.org/what-we-do/cybersecurity/)
    - [Research, Data & Emerging Technology Security](https://www.crdfglobal.org/what-we-do/research-data-and-technology-security/)
    - [Security Cooperation & Exchanges](https://www.crdfglobal.org/what-we-do/international-exchanges/)
    - [Border Security & Strategic Trade Controls](https://www.crdfglobal.org/what-we-do/strategic-trade-border-security/)
    - [Health Security & Research](https://www.crdfglobal.org/what-we-do/global-health/)
- HOW WE DELIVER 
    - [Travel & Logistics](https://www.crdfglobal.org/capabilities/travel-logistics/)
    - [Security Strengthening](https://www.crdfglobal.org/capabilities/security-strengthening/)
    - [Fellowships & Exchanges](https://www.crdfglobal.org/capabilities/fellowships-and-exchanges/)
    - [Grants & Research Competitions](https://www.crdfglobal.org/capabilities/grants-research-competitions/)
    - [Technical & Professional Training](https://www.crdfglobal.org/capabilities/technical-and-professional-trainings/)
    - [Specialized Equipment Procurement](https://www.crdfglobal.org/capabilities/specialized-equipment-procurement/)
    - [Program Design and Management](https://www.crdfglobal.org/integrated-solutions/program-design-and-management/)
    - [Monitoring, Evaluation and Learning](https://www.crdfglobal.org/integrated-solutions/monitoring-evaluation-and-learning/)
    - [Remote Training & Learning](https://www.crdfglobal.org/integrated-solutions/remote-training-and-learning/)
    - [Quality Framework](https://www.crdfglobal.org/integrated-solutions/quality-framework/)
- COLLABORATE 
    - [Become a Partner](https://www.crdfglobal.org/become-a-partner/)
    - [Grants & Procurement](https://www.crdfglobal.org/grants-procurement/)
    - [Procurement & RFPs](https://insights.crdfglobal.org/rfp?hsLang=en)
    - [Funding & Grants](https://insights.crdfglobal.org/funding-opportunities?hsLang=en)
- [WHERE WE WORK](https://crdfglobal.org/where-we-work/) 
    - [NEWS & INSIGHTS](https://www.crdfglobal.org/news/)
    - [CAREERS](https://www.crdfglobal.org/careers/)

[Privacy Policy](https://www.crdfglobal.org/data-privacy-policy/)    [Code of Conduct](https://www.crdfglobal.org/participant-code-of-conduct/)

© 2026 CRDF Global - All rights reserved